Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1614909 | Sodium Tartrate Dihydrate | 4 x 500 mg |
| USP-1615107 | Sodium Thiosulfate | 1 g |
| USP-1615708 | Somatropin (8.63 USP Somatropin Units/vial) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | unit |
| USP-1615956 | Sorbic Acid | 1 g |
| USP-1616008 | 1,4-Sorbitan | 300 mg |
| USP-1617000 | Sorbitol | 125 mg |
| USP-1617408 | Sotalol Hydrochloride (HCl) | 300 mg |
| USP-1617419 | Sotalol Related Compound A - N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride | 50 mg |
| USP-1617420 | Sotalol Related Compound B - N(4-Formylphenyl)methanesulfonamide | 50 mg |
| USP-1617430 | Sotalol Related Compound C - N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) | 50 mg |
| USP-1617474 | Defatted Powdered Soy | 2,5 g |
| USP-1618003 | Spectinomycin Hydrochloride | 200 mg |
| USP-1619006 | Spironolactone | 125 mg |
| USP-1619017 | Spironolactone Related Compound A - Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21,17-carbolactone) (AS) | 100 mg |
| USP-1619505 | Squalane | 500 mg |
| USP-1620005 | Stanozolol CIII (controlled substance in USA) | 200 mg |
| USP-1620209 | Stavudine | 250 mg |
| USP-1620220 | Stavudine System Suitability Mixture | 10 mg |
| USP-1621008 | Stearic Acid | 500 mg |
| USP-1621507 | Stearoyl Polyoxyglycerides | 100 mg |
| USP-1622000 | Stearyl Alcohol | 125 mg |
| USP-1622317 | Steviol Glycosides System Suitability | 50 mg |
| USP-1622350 | Steviolbioside | 100 mg |
| USP-1622408 | Stevioside | 30 mg |
| USP-1623003 | Streptomycin Sulfate | 200 mg |
| USP-1623411 | Succinic Acid | 100 mg |
| USP-1623502 | Succinylcholine Chloride | 500 mg |
| USP-1623604 | Succinylmonocholine Chloride | 125 mg |
| USP-1623615 | Sucrose Octaacetate | 500 mg |
| USP-1623626 | Sucralose | 400 mg |
| USP-1623637 | Sucrose | 100 mg |
| USP-1623659 | Sucromalt | 200 mg |
| USP-1623670 | Sulbactam (COLD SHIPMENT REQUIRED) | 250 mg |
| USP-1623681 | Sulconazole Nitrate | 200 mg |
| USP-1623706 | Sulfabenzamide | 200 mg |
| USP-1623808 | Sulfacetamide | 300 mg |
| USP-1624006 | Sulfacetamide Sodium | 500 mg |
| USP-1624505 | Sulfachlorpyridazine | 200 mg |
| USP-1625009 | Sulfadiazine | 200 mg |
| USP-1626001 | Sulfadimethoxine | 200 mg |
| USP-1626500 | Sulfadoxine | 200 mg |
| USP-1628007 | Sulfamerazine | 500 mg |
| USP-1629000 | Sulfamethazine | 1 g |
| USP-1630009 | Sulfamethizole | 200 mg |
| USP-1631001 | Sulfamethoxazole | 200 mg |
| USP-1631500 | Sulfamethoxazole N4-glucoside | 25 mg |
| USP-1632004 | Sulfanilamide | 5 g |
| USP-1633007 | Sulfanilamide Melting Point Standard (Approximately 165 °C) | 500 mg |
| USP-1633506 | Sulfanilic Acid | 200 mg |
| USP-1634000 | Sulfapyridine | 200 mg |
| USP-1635002 | Sulfapyridine Melting Point Standard (Approximately 191 degrees) | 1 g |
| USP-1635206 | Sulfaquinoxaline | 200 mg |
| USP-1635228 | Sulfaquinoxaline Related Compound A - N1-N2-diquinoxalin-2-ylsulfanilamide | 25 mg |
| USP-1636005 | Sulfasalazine | 125 mg |
| USP-1636504 | Sulfathiazole | 350 mg |
| USP-1636800 | Allyl Sulfide | 5 x 0,5 mL |
| USP-1637008 | Sulfinpyrazone | 200 mg |
| USP-1638000 | Sulfisoxazole | 200 mg |
| USP-1639003 | Sulfisoxazole Acetyl | 200 mg |
| USP-1642008 | Sulindac | 200 mg |
| USP-1642019 | Sulindac Related Compound A - trans-sulindac | 20 mg |
| USP-1642100 | Sulisobenzone | 500 mg |
| USP-1642154 | Sumatriptan | 50 mg |
| USP-1642201 | Sumatriptan Succinate | 200 mg |
| USP-1642212 | Sumatriptan Succinate Related Compound A - [3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethansulfonamide, succinate salt | 15 mg |
| USP-1642223 | Sumatriptan Succinate Related Compound C - [3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]- N-methylmethanesulfonamide succinate salt | 50 mg |
| USP-1642256 | Sumatriptan Succinate Related Impurities | 25 mg |
| USP-1642507 | Suprofen | 200 mg |
| USP-1642700 | Tacrine Hydrochloride (HCl) | 500 mg |
| USP-1642802 | Tacrolimus | 150 mg |
| USP-1642813 | Tacrolimus Related Compound A - (E)-17-ethyl-1,14-dihydroxy-12[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0super4,9]octacos-18-ene-2,3,10,16-tetrone | 15 mg |
| USP-1642857 | Tacrolimus System Suitability Mixture | 10 mg |
| USP-1642879 | Tadalafil | 200 mg |
| USP-1642904 | Tagatose | 200 mg |
| USP-1643260 | Tamsulosin Hydrochloride (HCl) | 200 mg |
| USP-1643281 | Racemic Tamsulosin Hydrochloride (HCl) | 50 mg |
| USP-1643292 | Racemethionine | 200 mg |
| USP-1643306 | Tamoxifen Citrate | 200 mg |
| USP-1643328 | Tannic Acid (AS) | 2 g |
| USP-1643339 | Tanshinone IIA | 20 mg |
| USP-1643340 | Tartaric Acid | 1 g |
| USP-1643361 | Taurine | 100 mg |
| USP-1643383 | Tazobactam | 200 mg |
| USP-1643394 | Tazobactam Related Compound A - (2S,3S)2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid | 20 mg |
| USP-1643419 | Telmisartan | 200 mg |
| USP-1643420 | Telmisartan Related Compound A - 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole | 20 mg |
| USP-1643437 | Telmisartan Related Compound B - 4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl) methyl]biphenyl-2-carboxylic acid | 15 mg |
| USP-1643452 | Terazosin Hydrochloride (HCl) | 200 mg |
| USP-1643463 | Terazosin Related Compound A - 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride | 50 mg |
| USP-1643474 | Terazosin Related Compound B - 1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine | 50 mg |
| USP-1643485 | Terazosin Related Compound C - 1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride | 25 mg |
| USP-1643496 | Terbinafine Hydrochloride (HCl) | 200 mg |
| USP-1643500 | Terbutaline Sulfate | 125 mg |
| USP-1643510 | Terbutaline Related Compound A - tert-butylamino-3,5-dihydroxyacetophenone sulfate | 50 mg |
| USP-1643532 | Terbinafine Related Compound B - (2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1- amine hydrochloride | 25 mg |
| USP-1643543 | Temozolomide | 200 mg |
| USP-1643554 | Temozolomide Related Compound A - 4-diazo-4H-imidazole-5-carboxamide | 15 mg |
| USP-1643565 | Temozolomide Related Compound B - 3-methyl-1,1-dihenylurea | 15 mg |
| USP-1643576 | Temozolomide Related Compound C - diphenylcarbamic chloride | 15 mg |
| USP-1643601 | Tenofovir | 15 mg |